Form D · Other Health Care
Emerald TopCo, Inc.
New York, NY · CIK 0001688674
Offering snapshot reported Dec 21, 2016 · SEC filing
- Reported sold
- $1.55M Offering amount: $1.55M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $300K Reported outside-investor minimum
- First sale
- Dec 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2016 | Initial | $1,550,000 | No comparison | 3 | SEC filing |
| Nov 4, 2016 | Initial | $1,339,180,083 | No comparison | 32 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276789
Source: Form D, filed Dec 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Bradburn | Executive |
| Jonathan Brook | Executive |
| Julie Gilbert | Director |
| Bernhard Hampl | Director |
| Jason Howard | Executive |
| Harry Klagsbrun | Director |
| Eric Liu | Director |
| Patrick T. Ryan | Director |
| Mark Tabak | Director |
| Ethan Waxman | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1114 Avenue Of The Americas, 45 Th Floor
New York, NY, 10036
New York, NY, 10036